NCT06060236 is a Phase 4 clinical trial of Ibuprofen 800 mg in Pain, sponsored by Ankara City Hospital Bilkent.

Who is sponsoring NCT06060236?

NCT06060236 is sponsored by Ankara City Hospital Bilkent.

What drugs are being tested in NCT06060236?

Interventions in NCT06060236: Ibuprofen 800 mg, Dexketoprofen.

What condition does NCT06060236 study?

NCT06060236 studies Pain, Bone Fracture.

Is NCT06060236 still recruiting?

NCT06060236 is currently status unknown. Last updated 2 October 2023.

Last reviewed 2023-10-02 · How we verify

NCT06060236

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Dexketoprofen and Ibuprofen in Long Bone Fractures

Status unknown Phase 4 Last updated 2 October 2023

What this trial tests

Phase 4 trial testing Ibuprofen 800 mg in Pain in 100 participants. Status unknown.

Timeline

1 September 2023

Primary endpoint
1 September 2024

1 September 2024

Quick facts

Lead sponsor	Ankara City Hospital Bilkent
Phase	Phase 4
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	treatment
Enrollment	100
Start date	1 September 2023
Primary completion	1 September 2024
Estimated completion	1 September 2024
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Ibuprofen 800 mg — full drug profile →
Dexketoprofen (DEXKETOPROFEN) — full drug profile →

Conditions studied

Pain — all drugs for Pain →
Bone Fracture — all drugs for Bone Fracture →

Sponsor

Ankara City Hospital Bilkent

Who can join

Adults 18 to 80, any sex, with Pain or Bone Fracture. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study was to compare the efficacy of ibuprofen and dexketoprofen, two common analgesic drugs used in pain control in patients with long bone fractures.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Ibuprofen 800 mg

Trials testing the same drug.

NCT06088732 — Effects of Acute Exercise and Ibuprofen on Symptoms, Immunity, and Neural Circuits in Bipolar Depression · Phase 1, PHASE2 · recruiting
NCT05907993 — Ibuprofen Versus Ketorolac For Postoperative Pain Relief After Cesarean Section · Phase 4 · completed
NCT05610384 — Ibuprofen Versus Ketorolac for Perioperative Pain Control After Open Hysterectomy · NA · completed
NCT05630222 — Evaluation of Effect of Intravenous Morphine vs Intravenous Ibuprofen and Acetaminophen vs Intravenous Ibuprofen · Phase 3 · completed
NCT05512013 — The Effects of NSAIDs on Bone Metabolism Following Exercise · Phase 1 · completed

Other recruiting trials for Pain

Currently open trials in the same condition.

NCT07533409 — Tactile and Pain Sensory Thresholds and Hand Grip Strength · recruiting
NCT07294092 — Ketamine and Propofol NeuroImaging · EARLY_PHASE1 · recruiting
NCT07290205 — Remimazolam NeuroImaging · EARLY_PHASE1 · recruiting
NCT07487610 — Relationship Between Neuropathic Pain and Geriatric Assessment Parameters in Patients Aged 80 Years and Older · recruiting
NCT07454993 — The Effect of Music During Colonoscopy · NA · recruiting

Other Ankara City Hospital Bilkent trials

Trials by the same sponsor.

NCT07496788 — Investigation of the Role of Internal Jugular Vein Collapsibility Index in Predicting Spinal Anesthesia-Induced Hypotens · not yet recruiting
NCT07536464 — PEEP Strategies and Mechanical Power in Robotic Surgery · NA · not yet recruiting
NCT07534553 — Mechanical Power Ventilation in RALP · NA · not yet recruiting
NCT07501468 — Ventilation Safety in Beach Chair Shoulder Surgery: SafeLM Versus I-gel · NA · not yet recruiting
NCT07502209 — Suprascapular Nerve PRF in Chronic Shoulder Pain · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06060236 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ankara City Hospital Bilkent
Last refreshed: 2 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06060236.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing